However, a causal mutation in MYH9 remained elusive, as did an explanation for why these common, intronic MYH9 polymorphisms were present at such high frequency in African-American and West African populations, and an explanation for why the majority of African-Americans with 2 copies of these polymorphisms were unaffected by kidney disease. This evidence concerns the gene MYH9 and kidney disorder.